FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24684411000001102: Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Jul 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80190801000001118 Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80190901000001112 Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Is a Drospirenone 3mg / Ethinylestradiol 30microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has AMP Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start